Neutralizing anti-IL-10 antibody upregulates the induction and elicitation of contact hypersensitivity

Journal of Interferon and Cytokine Research

Volumn 17, Issue 12, 1997, Pages 763-768

  Maguire Jr , Henry C ^a,b   Ketcha, Karen A ^a   Lattime, Edmund C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROTON OIL; INTERLEUKIN 10; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTACT ALLERGY; DOWN REGULATION; FEMALE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA; CROTON; MURINAE;

EID: 0031444325     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.763     Document Type: Article

References (28)

1. FIORENTINO, D.F., BOND, M.W., and MOSMAN, T.R. (1989). Two types of mouse T helper cell IV. th-2 clones secrete a factor that inhibits cytokine production by th-1 clones. J. Exp. Med. 170, 2081-2095.
2. ENK, A.H., and KATZ, S.I. (1992). Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149, 92-95.
3. FIORENTINO, D.F., ZLOTNIK, A., VIEIRA, P., MOSMANN, T.R., HOWARD, M., MOORE, K.W., and O'GARRA, A. (1991). IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th-1 cells. J. Immunol. 146, 3444-3461.
4. THOMPSON-SNIPES, L., DHAR, V., BOND. M.W., MOSMANN, T.K., MOORE, K.W., and RENNICK, D.M. (1991). Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510.
5. O'GARRA, A., CHANG, R., GO, N., HASTINGS, R., HAUGHTON, G., and HOWARD, M. (1992). Ly-1B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22, 711-717.
6. BOGDAN, C., VODOVOTY, Y., and NATHAN, C. (1991). Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
7. ENK, A.H., ANGELONI, V.L., UDEY, M.C., and KATZ, S.I. (1993). Inhibition of Langerhans cell antigen-presenting function by IL-10. J. Immunol. 151, 2390-2398.
8. SCHWARZ, A., GRABBLE, S., RIEMANN, H., ARAGAVE, Y., SIMON, M., MANON, S., ANDRADE, S., LUGER, T., ZLOTNIK, A., and SCHWARZ, T. (1994). in vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103, 211-216.
9. ENK, A.H., SALOGA, J., BECKER, D., MOHAMADZEDEH, M., and KNOP, J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402.
10. KOUDO, S., McKENZIE, R.C., and SAUDER, D.N. (1994). Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 103, 811-814.
11. MAGUIRE, H.C., JR. (1995). Murine recombinant interleukin-12 increases the acquisition of allergic contact dermatitis in the mouse. Int. Arch. Allergy Immunol. 106, 166-168.
12. ASHERSON, G., and PTAK, W.L. (1969). Contact and delayed hypersensitivity in the mouse. 1. Active sensitization and passive transfer. Immunology 14, 405-416.
13. SIEGEL, S. (1956). Nonparametric Statistics. New York: Mc-Graw-Hill.
14. BERG, D.J., LEACH, M.W., KUHN, R., RAJEWSKY, K., MULLER, W., DAVIDSON, N.J., and RENNICK, D. (1995). Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182, 99-108.
15. D'ANDREA, A., ASTE-AMEZAGA, M., VALIANTE, N.M., MA, X., KUBIN, M., and TRINCHIERI, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048.
16. FERGUSON, T.A., DUBE, P., and GRIFFITH, T.S. (1994). Regulation of contact hypersensitivity by interleukin-10. J. Exp. Med. 179, 1597-1604.
17. SILVA, J.S., MORRISSEY, P.J., GRABSTEIN, K.H., MOHLER, K.M., ANDERSON, D., and REED, S.G. (1992). Interleukin 10 and interferon regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175, 169-174.
18. SIELING, P.A., ABRAMS, J.S., YAMAMURA, M., SALGAME, P., BLOOM, B.R., REA, T.H., and MODLIN, R.L. (1993). Immunosuppressive roles for IL-10 and IL-4 in human infection, in vitro modulation of T cell responses in leprosy. J. Immunol. 150, 5501-5510.
19. CARVALHO, E.M., BACELLAR, O., BROWNELL, C., REGIS, T., COFFMAN, R.L., and REED, S.G. (1994). Restoration of IFN production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152, 5949-5956.
20. TONNETTI, I., SPACCAPELO, R., CENCI, E., MENCACCI, A., PUCCETTI, P., COFFMAN, R.L., BISTONI, F., and ROMANI, L. (1995). Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25, 1559-1565.
21. WALLEY, K.R., LUKACS, M.W., STANDIFORD, T.J., STREITER, R.M., and KUNKEL, S.L. (1996). Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64, 4733-4738.
22. ISHIDA, H., HASTINGS, R., KEARNEY, J., and HOWARD, M. (1992). Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175, 1213-1220.
23. KUHN, R., LOHLER, J., RENNICK, D., RAJEWSKY, K., and MULLER, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
24. CHEN, Q., DANIEL, V., MAHER, D.W., and HERSEY, P. (1994). Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56, 755-760.
25. LATTIME, E.C., MASTRANGELO, M.J., BAGASRA, O., LI, W., and BERD, D. (1995). Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol. Immunother. 41, 151-156.
26. EMILIE, D., TOUITON, R., RAPHAEL, M., PEUCHMAWR, M., DEVERGUEE, O., KEA, D., COUMBRARAS, J., CREVOU, M.-C., EDELMAN, L., JOAB, I., and GALANAUD, P. (1992). In vivo production of interleukin-10 by malignant cells in AIDS lymphoma. Eur. J. Immunol. 22, 2937-2942.
27. HUETTNER, C., PAULUS, W., and ROGGENDROF, W. (1995). Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146, 317-322.
28. KNOLFEL, B., NUSKE, K., STEINER, T., JUNKER, K., KOSMEHL, H., REBSTOCK, K., REINHOLD, D., and JUNKER, U. (1997). Renal cell carcinomas produce IL-6, IL-10, IL-11 and TGF-β1 in primary cultures and modulates T lymphocyte blast transformation. J. Interferon Cytokine Res. 17, 95-102.